Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Diseases
Alzheimer's Disease
Dementia
Dementia with Lewy Bodies
Frontotemporal Dementia
Vascular Dementia
Mild Cognitive Impairment
View all Diseases
Topics
Diagnostics
Biology
Biomarkers
Treatment
Clinical Care
Prevention
View all Topics
Conferences
AAIC 2023
BNA 2023
AD/PD 2023
ARUK 2023
CTAD 2022
AAIC 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Giovanni Frisoni
1:56
Best outcome measures for Alzheimer’s disease follow-up in the clinic
Giovanni Frisoni
• 30 Mar 2023
1:36
Exploring the potential role of amyloid deposition in the gut in Alzheimer’s disease
Giovanni Frisoni
• 30 Mar 2023
4:20
Defining subgroups of patients with subjective cognitive decline more likely to progress
Giovanni Frisoni
• 30 Mar 2023
4:51
European task force recommendations: shifting memory clinics towards prevention
Giovanni Frisoni
• 30 Mar 2023
3:28
Reframing the way we think about Alzheimer’s disease
Giovanni Frisoni
• 11 Mar 2022
2:55
Revising the amyloid hypothesis in Alzheimer’s disease: the probabilistic model
Giovanni Frisoni
• 11 Mar 2022
1:40
Blood-based biomarkers for Alzheimer’s disease screening
Giovanni Frisoni
• 11 Mar 2022
2:41
Ethical considerations of biomarker use in prodromal Alzheimer’s disease
Giovanni Frisoni
• 29 May 2016
4:32
The landscape of biomarkers for the management of Alzheimer’s disease
Giovanni Frisoni
• 29 May 2016
2:58
Task force from Geneva: Roadmap for biomarker validation in Alzheimer’s disease
Giovanni Frisoni
• 29 May 2016